Skip to main content
Equibles
PTGX logo

PTGX · Protagonist Therapeutics, Inc

Track PTGX — free

Use PTGX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PTGX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$157.43 +2.33 (+1.50%)
Market Cap
$10.04B
Shares
64.71M

Protagonist Therapeutics, Inc Earnings Call Transcripts

Every quarterly earnings call for Protagonist Therapeutics, Inc (PTGX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲15.6% $2.72M −$17.50M '19 Q4 20-03-10 ▲184.4% $170.64M $131.67M '24 Q4 25-02-21 ▼88.9% $28.32M −$11.65M '25 Q1 25-05-06 ▲33.1% $5.55M −$34.77M '25 Q2 25-08-06 LATEST ▲3749.2% $213.47M $162.85M '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
Protagonist Therapeutics, Inc Q2 FY2026 Earnings Call
Revenue
$213.47M
▲ 3749.2% YoY
Diluted EPS
$2.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Protagonist at the Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-12
Barclays Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-08-06
Protagonist Therapeutics, Inc Q2 FY2025 Earnings Call
Revenue
$5.55M
▲ 33.1% YoY
Diluted EPS
$-0.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Protagonist Therapeutics, Inc Q1 FY2025 Earnings Call
Revenue
$28.32M
▼ 88.9% YoY
Diluted EPS
$-0.19
▼ 105.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-21
Protagonist Therapeutics, Inc Q4 FY2024 Earnings Call
Revenue
$170.64M*
▲ 184.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-10
Protagonist Therapeutics, Inc Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q1
2020-05-07
Protagonist Therapeutics, Inc Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Protagonist Therapeutics, Inc Q4 FY2019 Earnings Call
Revenue
$2.72M
▲ 15.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–9 of 9 earnings calls
Key facts CIK 1377121 CUSIP 74366E102 13F (30d) 339 filings 319 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)